The solid progress of nanomedicine

João Pedro Martins, José das Neves, María de la Fuente, Christian Celia, Helena Florindo, Nazende Günday-Türeli, Amirali Popat, José Luis Santos, Flávia Sousa, Ruth Schmid, Joy Wolfram, Bruno Sarmento, Hélder A. Santos

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. [Figure not available: see fulltext.].

Original languageEnglish (US)
Pages (from-to)726-729
Number of pages4
JournalDrug Delivery and Translational Research
Volume10
Issue number3
DOIs
StatePublished - Jun 1 2020

Keywords

  • Cancer therapy
  • Clinical translation
  • Nanomedicine
  • Nanotechnology
  • Reproducibility

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'The solid progress of nanomedicine'. Together they form a unique fingerprint.

  • Cite this

    Martins, J. P., das Neves, J., de la Fuente, M., Celia, C., Florindo, H., Günday-Türeli, N., Popat, A., Santos, J. L., Sousa, F., Schmid, R., Wolfram, J., Sarmento, B., & Santos, H. A. (2020). The solid progress of nanomedicine. Drug Delivery and Translational Research, 10(3), 726-729. https://doi.org/10.1007/s13346-020-00743-2